Edaravone attenuates lipopolysaccharide-induced acute respiratory distress syndrome associated early pulmonary fibrosis via amelioration of oxidative stress and transforming growth factor-β1/Smad3 signaling (Q47441751)
Jump to navigation
Jump to search
scientific article published in November 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Edaravone attenuates lipopolysaccharide-induced acute respiratory distress syndrome associated early pulmonary fibrosis via amelioration of oxidative stress and transforming growth factor-β1/Smad3 signaling |
scientific article published in November 2017 |
Statements
Edaravone attenuates lipopolysaccharide-induced acute respiratory distress syndrome associated early pulmonary fibrosis via amelioration of oxidative stress and transforming growth factor-β1/Smad3 signaling (English)
Xida Wang
Rongde Lai
Xiangfen Su
Guibin Chen
Zijing Liang
1 November 2017
495
706-712